Veradermics posts $819.9m war chest and full slate of late-stage trial data as it races to become first FDA-approved oral ...
Alzheimer’s trial needing 760. For a biotech betting everything on one pill, that’s the good kind of surprise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results